Stock listing
NASDAQ:TPST Tempest Therapeutics, Inc. Stock
Home listing (NASDAQ) of Tempest Therapeutics, Inc.
Follow Tempest Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:TPST
$0.635 USD -0.046 (-6.8%)
Close on Oct 14, 2026

- Ticker
- NASDAQ:TPST
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Sep 23, 2026
Tempest Appoints Global Finance Leader Nancy Freda-Smith to Board of Directors
Latest deck · Sep 15, 2026
Investor Presentation (September 2026)
Investor deck · 11 slides
Latest news
Financings
Private placement of shares of common stock (or pre-funded warrants) with series C and series D warrants
Sep 11, 2026
Announced: about US$2.5M · US$0.805 a share · Warrants at US$0.805 · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: Working capital and other general corporate purposes
Decks
Investor Presentation (September 2026)
Investor deck · 11 slides · Sep 15, 2026
Investor Presentation (May 2026)
Investor deck · 23 slides · May 6, 2026
Investor Presentation (February 2026)
Investor deck · 40 slides · Feb 11, 2026
Millendo Therapeutics — Merger or Acquisition (March 2021)
Merger or acquisition · 23 slides · Mar 29, 2021
Tempest Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 24 in the last 12 months · 87 in all · newest Sep 23, 2026 · oldest 2021
- Decks
- 12 decks · latest Sep 15, 2026
Where Tempest Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:TPST · Home listing · This page | NASDAQ | United States | USD |
| BOATS:TPST | BOATS | United States | USD |
| gettex:3OS0 | gettex | Germany | EUR |
| Frankfurt:3OS0 | Frankfurt | Germany | EUR |
| Lang & Schwarz:A41556 | Lang & Schwarz | Germany | EUR |
| LS Exchange:A41556 | LS Exchange | Germany | EUR |
| Munich:3OS0 | Munich | Germany | EUR |
Log in to ask 6ix AI your own questions about Tempest Therapeutics, Inc.